restor3d secures $104M to scale patient-specific orthopaedic solutions

restor3d, Inc., a provider of patient-specific musculoskeletal implants based in Durham, North Carolina, USA, has announced a strategic investment partnership with Partners Group. Under the agreement, Partners Group will acquire a significant minority stake in restor3d, marking the company’s first institutional investment.

As part of this transaction, restor3d has raised a total of $104 million, including $65 million of new equity from Partners Group and $39 million from existing shareholders. The proceeds from the investment will support continued product innovation, commercial expansion, and wider access to personalised orthopaedic care.

Partners Group will also join restor3d’s board of directors, contributing its deep operational experience and healthcare expertise to support the company’s long-term strategy.

“This investment marks an exciting milestone for restor3d as we expand access to personalised orthopaedic solutions,” Kurt Jacobus, CEO of restor3d, shared. “With Partners Group’s support, we will continue to deliver innovations that empower surgeons and improve outcomes for patients across the full spectrum of joint replacement.”

Ashley Torres, Member of Management, Private Equity, Partners Group, stated, “restor3d is solving a key issue in the orthopaedic market, namely that procedures have often relied on off-the-shelf products that cannot accommodate different patient anatomies. restor3d addresses this challenge by delivering rapid, precise patient-specific implants that lead to better surgical fit and function, ultimately improving patient outcomes.”

Todd Miller, Partner, Head Private Equity Health & Life, Partners Group, added, “We think restor3d’s offering is set to benefit from several thematic trends, including ageing demographics and rising engagement in sports and recreational activities in the US. We look forward to working with the company’s highly experienced management team.”

www.restor3d.com